|
WO1996037226A2
(en)
*
|
1995-05-26 |
1996-11-28 |
Pfizer Inc. |
Combinations for the treatment of parkinsonism containing selective nmda antagonists
|
|
ATE325610T1
(de)
*
|
1997-09-05 |
2006-06-15 |
Kyowa Hakko Kogyo Kk |
Xanthinderivative zur behandlung von hirnischämie
|
|
EP1178835A4
(en)
|
1999-05-10 |
2002-08-21 |
Univ Princeton |
COMPOSITIONS AND METHODS FOR IMPROVING LEARNING AND REMEMBERABILITY
|
|
US6316474B1
(en)
|
1999-10-29 |
2001-11-13 |
Merck & Co., Inc. |
2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
|
|
US6476041B1
(en)
|
1999-10-29 |
2002-11-05 |
Merck & Co., Inc. |
1,4 substituted piperidinyl NMDA/NR2B antagonists
|
|
US6432976B1
(en)
|
1999-10-29 |
2002-08-13 |
Merck & Co., Inc. |
8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
|
|
US6291499B1
(en)
|
1999-10-29 |
2001-09-18 |
Merck & Co., Inc. |
2-cyclohexyl benzimidazole NMDA/NR2B antagonists
|
|
AU1153601A
(en)
|
1999-10-29 |
2001-05-08 |
Merck Sharp & Dohme Limited |
Method to treat pain utilizing benzimidazole NMDA NR2B antagonists
|
|
US6489477B1
(en)
|
1999-10-29 |
2002-12-03 |
Merck & Co., Inc. |
2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
|
|
US6369076B1
(en)
|
1999-10-29 |
2002-04-09 |
Merck & Co. Inc. |
5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
|
|
GB0015488D0
(en)
|
2000-06-23 |
2000-08-16 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2002000629A1
(en)
|
2000-06-26 |
2002-01-03 |
Merck & Co., Inc. |
Iminopyrimidine nmda nr2b receptor antagonists
|
|
WO2002009736A1
(en)
|
2000-07-27 |
2002-02-07 |
Washington University |
Methods and agents for treating persistent pain
|
|
AU2001280996A1
(en)
|
2000-08-04 |
2002-02-18 |
Cis Biotech, Inc. |
Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke
|
|
HU227197B1
(en)
|
2000-10-24 |
2010-10-28 |
Richter Gedeon Nyrt |
Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them
|
|
HUP0303258A3
(en)
|
2001-02-23 |
2004-06-28 |
Merck & Co Inc |
N-substituted nonaryl-heterocyclic nmda/nr2b antagonists and pharmaceutical compositions containing them
|
|
AU2002338334B8
(en)
|
2001-04-03 |
2008-09-18 |
Merck & Co., Inc. |
N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B antagonists
|
|
CA2449249A1
(en)
|
2001-06-12 |
2002-12-19 |
Merck & Co., Inc. |
Nr2b receptor antagonists for the treatment or prevention of migraines
|
|
SI1409477T1
(sl)
|
2001-07-24 |
2009-02-28 |
Richter Gedeon Nyrt |
Derivati piperidina kot antagonisti nmda-receptorjev
|
|
AU2003230758A1
(en)
|
2002-04-02 |
2003-10-20 |
Merck And Co., Inc. |
5h-benzo(4,5)cyclohepta(1,2-b)pyridine nmda/nr2b antagonists
|
|
US6713490B2
(en)
|
2002-04-26 |
2004-03-30 |
Pfizer, Inc. |
3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists
|
|
JP2006509763A
(ja)
|
2002-11-22 |
2006-03-23 |
メルク エンド カムパニー インコーポレーテッド |
Ｎｒ２ｂ受容体アンタゴニストとしての２−［（４−ベンジル）−１−ピペリジニル）メチル］ベンゾイミダゾール−５−オール誘導体
|
|
AU2003303042A1
(en)
|
2002-12-17 |
2004-07-09 |
Pfizer Inc. |
2-pyridyl and 2-pyrimidyl cycloalkylene amide compounds as nr2b receptor antagonists
|
|
US20060128694A1
(en)
|
2002-12-19 |
2006-06-15 |
Michael Grzelak |
Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
|
|
US20060106040A1
(en)
|
2002-12-19 |
2006-05-18 |
Michael Grzelak |
Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
|
|
EP1615636A1
(en)
|
2003-04-10 |
2006-01-18 |
Pfizer Inc. |
Bicyclic compounds as nr2b receptor antagonists
|
|
BRPI0410837A
(pt)
|
2003-06-04 |
2006-06-27 |
Merck & Co Inc |
composto, composição farmacêutica, e, método para tratar ou prevenir uma doença ou condição
|
|
WO2005019222A1
(en)
|
2003-08-15 |
2005-03-03 |
Merck & Co., Inc. |
4-cycloalkylaminopyrazolo pyrimidine nmda/nr2b antagonists
|
|
JP2007502772A
(ja)
|
2003-08-15 |
2007-02-15 |
メルク エンド カムパニー インコーポレーテッド |
４−シクロアルキルアミノピラゾロピリミジンｎｍｄａ／ｎｒ２ｂ拮抗薬
|
|
EP1666464A4
(en)
|
2003-09-25 |
2008-12-10 |
Shionogi & Co |
PIPERIDINE DERIVATIVE HAVING ANTAGONIST ACTIVITY OF THE NDMA RECEPTOR
|
|
MXPA06004038A
(es)
|
2003-10-08 |
2006-06-28 |
Pfizer |
Compuestos de 1-'2-(4-hidroxifenil)-2-hidroxietil-piperidin-4-ol como antagonsitas del receptor n-metil-d-aspartato.
|
|
WO2005035523A1
(en)
|
2003-10-08 |
2005-04-21 |
Pfizer Japan Inc. |
Fused lactam compounds
|
|
BRPI0507636A
(pt)
|
2004-02-11 |
2007-07-10 |
Pfizer |
compostos, derivados terapêuticos de amida, composição farmacêutica, uso dos mesmos e combinação
|
|
WO2005102390A2
(en)
|
2004-04-22 |
2005-11-03 |
Pfizer Japan, Inc. |
Combinations comprising alpha-2-delta ligands and nmda receptor antagonists
|
|
EP1753760B1
(en)
*
|
2004-05-24 |
2008-01-02 |
F.Hoffmann-La Roche Ag |
4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
|
|
HU226977B1
(en)
|
2004-07-29 |
2010-04-28 |
Richter Gedeon Nyrt |
Kynurenic acid amide derivatives, pharmaceutical compositions containing them and process for producing them
|
|
HUP0401522A2
(en)
|
2004-07-29 |
2006-04-28 |
Richter Gedeon Vegyeszet |
New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
|
|
US20070293515A1
(en)
|
2004-08-03 |
2007-12-20 |
Layton Mark E |
1,3-Disubstituted Heteroaryl Nmda/Nr2b Antagonists
|
|
WO2006083949A2
(en)
|
2005-02-01 |
2006-08-10 |
University Of Medicine And Dentistry Of New Jersey |
Sepsis prevention through adenosine receptor modulation
|
|
JP2008536927A
(ja)
|
2005-04-19 |
2008-09-11 |
メルク エンド カムパニー インコーポレーテッド |
Ｎ−アルキル−アザシクロアルキルｎｍｄａ／ｎｒ２ｂ拮抗物質
|
|
EP1885365A4
(en)
|
2005-05-13 |
2012-07-11 |
The Feinstein Inst Medical Res |
TREATMENT OF SEPSIS AND INFLAMMATION WITH ADRENEER ALPHA2A ANTAGONISTS
|
|
WO2006129626A1
(ja)
|
2005-05-30 |
2006-12-07 |
Kyowa Hakko Kogyo Co., Ltd. |
[1,2,4]トリアゾロ[1,5-c]ピリミジン誘導体の製造法
|
|
JPWO2006137527A1
(ja)
|
2005-06-23 |
2009-01-22 |
協和発酵キリン株式会社 |
チアゾール誘導体
|
|
WO2006137465A1
(ja)
|
2005-06-24 |
2006-12-28 |
Shionogi & Co., Ltd. |
含窒素複素環誘導体
|
|
WO2007006157A1
(en)
|
2005-07-14 |
2007-01-18 |
The University Of British Columbia |
Neuroprotective modulation of nmda receptor subtype activities
|
|
US7799947B2
(en)
|
2005-11-29 |
2010-09-21 |
Hammersmith Imanet Limited |
In vivo imaging compounds
|
|
WO2007063839A1
(ja)
|
2005-11-30 |
2007-06-07 |
Shionogi & Co., Ltd. |
シクロヘキサン誘導体
|
|
EP1988077A4
(en)
|
2006-02-23 |
2009-09-02 |
Shionogi & Co |
NUCLEIC HETEROCYCLIC DERIVATIVES SUBSTITUTED BY CYCLIC GROUPS
|
|
JP2010509189A
(ja)
*
|
2006-06-26 |
2010-03-25 |
シェーリング コーポレイション |
アデノシンＡ２ａレセプターアンタゴニスト
|
|
BRPI0719056A2
(pt)
|
2006-11-09 |
2013-11-26 |
Ct De Rech Public De La Sante |
Uso de um antagonista de adenosina
|
|
EP2162742B1
(en)
|
2007-06-19 |
2015-09-30 |
Rajiv Gandhi Centre For Biotechnology |
Assay for detection of transient intracellular ca2+
|
|
EP2184272A4
(en)
|
2007-08-21 |
2011-11-09 |
Shionogi & Co |
PIPERAZINE DERIVATIVE
|
|
US20090181934A1
(en)
|
2007-10-17 |
2009-07-16 |
Novartis Ag |
Organic Compounds
|
|
CN101835759A
(zh)
|
2007-10-24 |
2010-09-15 |
詹森药业有限公司 |
芳基茚并嘧啶及其作为腺苷A2a受体拮抗剂的用途
|
|
WO2009054544A1
(en)
*
|
2007-10-26 |
2009-04-30 |
Eisai R & D Management Co., Ltd. |
Ampa receptor antagonists for parkinson's disease and movement disorders
|
|
EP2215073A4
(en)
|
2007-10-31 |
2011-04-06 |
Merck Sharp & Dohme |
SLEEP MODULATION WITH NR2B RECEPTOR ANTAGONISTS
|
|
KR20100135847A
(ko)
|
2008-03-27 |
2010-12-27 |
에보텍 뉴로사이언시즈 게엠베하 |
Ｎｍｄａ ｎｒ２ｂ―서브타입 선택적 길항제를 사용한 질병 치료 방법
|
|
US8684624B2
(en)
|
2008-07-01 |
2014-04-01 |
Saint-Gobain Performance Plastics Rencol Limited |
Tolerance ring
|
|
EP2144462A1
(en)
|
2008-07-09 |
2010-01-13 |
Nokia Siemens Networks OY |
Reduced resource allocation parameter signalling
|
|
EP2297715A1
(de)
|
2008-07-09 |
2011-03-23 |
Siemens Aktiengesellschaft |
Verfahren, kommunikationsverbund und software zum auffinden von gesuchten objekten
|
|
US20110190348A1
(en)
*
|
2008-08-21 |
2011-08-04 |
Pradeep Banerjee |
Methods for treating cns disorders
|
|
RU2011115815A
(ru)
|
2008-09-29 |
2012-11-10 |
Гайлид Сайэнсиз, Инк. (Us) |
Комбинации средства, регулирующего частоту сердечных сокращений и агониста а-2-альфа рецепторов для применения в способах мультидетекторной компьютерной томографии
|
|
WO2010040003A2
(en)
|
2008-10-01 |
2010-04-08 |
The Scripps Research Institute |
Human a2a adenosine receptor crystals and uses thereof
|
|
US8282042B2
(en)
|
2009-06-22 |
2012-10-09 |
The Boeing Company |
Skin panel joint for improved airflow
|
|
US8301311B2
(en)
|
2009-07-06 |
2012-10-30 |
Siemens Aktiengesellschaft |
Frequency-responsive wind turbine output control
|
|
US20110007639A1
(en)
|
2009-07-10 |
2011-01-13 |
Qualcomm Incorporated |
Methods and apparatus for detecting identifiers
|
|
US20110105540A1
(en)
|
2009-10-29 |
2011-05-05 |
Jackson Paul F |
2-AMINO-9-[4-(4-METHOXY-PHENOXY)-PIPERIDIN-1-YL]-4-PHENYL-INDENO[1,2-D]PYRIMIDIN-5-ONE AND ITS USE AS A HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONIST
|
|
DE102010026274A1
(de)
|
2010-07-06 |
2012-01-12 |
Voith Patent Gmbh |
Bremsanlage und Verfahren zum Einstellen eines Bremsmomentes einer solchen
|
|
US9006177B2
(en)
*
|
2010-09-24 |
2015-04-14 |
Advinus Therapeutics Limited |
Fused tricyclic compounds as adenosine receptor antagonist
|